Annual Shareholders Equity
$4.64 M
-$2.35 M-33.66%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual stockholders equity is $4.64 million, with the most recent change of -$2.35 million (-33.66%) on December 1, 2023.
- During the last 3 years, XRTX annual shareholders equity has risen by +$3.66 million (+371.17%).
- XRTX annual shareholders equity is now -64.84% below its all-time high of $13.20 million, reached on December 31, 2021.
Performance
XRTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.13 M
-$571.10 K-21.12%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly stockholders equity is $2.13 million, with the most recent change of -$571.10 thousand (-21.12%) on September 1, 2024.
- Over the past year, XRTX quarterly shareholders equity has dropped by -$2.51 million (-54.04%).
- XRTX quarterly shareholders equity is now -83.84% below its all-time high of $13.20 million, reached on December 1, 2021.
Performance
XRTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XRTX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -33.7% | -54.0% |
3 y3 years | +371.2% | -76.5% |
5 y5 years | +1866.1% | -76.5% |
XRTX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -64.8% | at low | -83.8% | at low |
5 y | 5-year | -64.8% | +2963.7% | -83.8% | +164.2% |
alltime | all time | -64.8% | +991.7% | -83.8% | +164.2% |
XORTX Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.13 M(-21.1%) |
Jun 2024 | - | $2.70 M(+8.6%) |
Mar 2024 | - | $2.49 M(-46.3%) |
Dec 2023 | $4.64 M(-33.7%) | $4.64 M(-23.7%) |
Sep 2023 | - | $6.09 M(-17.7%) |
Jun 2023 | - | $7.40 M(-18.3%) |
Mar 2023 | - | $9.06 M(+29.5%) |
Dec 2022 | $7.00 M(-47.0%) | $7.00 M(-10.6%) |
Sep 2022 | - | $7.83 M(-17.6%) |
Jun 2022 | - | $9.50 M(-11.5%) |
Mar 2022 | - | $10.73 M(-18.7%) |
Dec 2021 | $13.20 M(+1240.1%) | - |
Dec 2021 | - | $13.20 M(-497.3%) |
Sep 2021 | - | -$3.32 M(-224.1%) |
Jun 2021 | - | $2.68 M(-2.6%) |
Mar 2021 | - | $2.75 M(+179.1%) |
Dec 2020 | $985.20 K(-707.8%) | $985.20 K(-21.0%) |
Sep 2020 | - | $1.25 M(-15.0%) |
Jun 2020 | - | $1.47 M(-4.9%) |
Mar 2020 | - | $1.54 M(-1052.1%) |
Dec 2019 | -$162.10 K | -$162.10 K(+112.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | -$76.20 K(-585.4%) |
Jun 2019 | - | $15.70 K(-87.1%) |
Mar 2019 | - | $121.60 K(-48.5%) |
Dec 2018 | $236.10 K(-145.4%) | $236.10 K(-33.7%) |
Sep 2018 | - | $356.30 K(-37.4%) |
Jun 2018 | - | $568.90 K(-26.4%) |
Mar 2018 | - | $772.90 K(-248.5%) |
Dec 2017 | -$520.60 K(-487.4%) | -$520.60 K(-1687.2%) |
Nov 2017 | - | $32.80 K(-109.5%) |
Sep 2017 | - | -$346.70 K(-806.1%) |
Aug 2017 | - | $49.10 K(-49.0%) |
May 2017 | - | $96.30 K(-28.3%) |
Feb 2017 | $134.40 K(-157.0%) | $134.40 K(-59.7%) |
Dec 2016 | -$235.90 K(-219.6%) | - |
Nov 2016 | - | $333.10 K(+154.9%) |
Aug 2016 | - | $130.70 K(-23.6%) |
May 2016 | - | $171.10 K(-13.3%) |
Feb 2016 | $197.30 K(+105.7%) | $197.30 K(-14.3%) |
Nov 2015 | - | $230.20 K(+416.1%) |
Aug 2015 | - | $44.60 K(-47.5%) |
May 2015 | - | $85.00 K(-11.4%) |
Feb 2015 | $95.90 K | $95.90 K |
FAQ
- What is XORTX Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for XORTX Therapeutics?
- What is XORTX Therapeutics annual shareholders equity year-on-year change?
- What is XORTX Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly shareholders equity year-on-year change?
What is XORTX Therapeutics annual stockholders equity?
The current annual shareholders equity of XRTX is $4.64 M
What is the all time high annual shareholders equity for XORTX Therapeutics?
XORTX Therapeutics all-time high annual stockholders equity is $13.20 M
What is XORTX Therapeutics annual shareholders equity year-on-year change?
Over the past year, XRTX annual stockholders equity has changed by -$2.35 M (-33.66%)
What is XORTX Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of XRTX is $2.13 M
What is the all time high quarterly shareholders equity for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly stockholders equity is $13.20 M
What is XORTX Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, XRTX quarterly stockholders equity has changed by -$2.51 M (-54.04%)